您的购物车当前为空
别名 ASP-1707
Opigolix (ASP-1707)是一种可口服促性腺激素释放激素 (GnRH) 受体拮抗剂,可用于研究子宫内膜异位症相关疼痛、风湿性关节炎和子宫肌瘤。


为众多的药物研发团队赋能,
让新药发现更简单!
Opigolix (ASP-1707)是一种可口服促性腺激素释放激素 (GnRH) 受体拮抗剂,可用于研究子宫内膜异位症相关疼痛、风湿性关节炎和子宫肌瘤。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,980 | In Stock | |
| 5 mg | ¥ 4,920 | In Stock | |
| 10 mg | ¥ 6,870 | In Stock | |
| 25 mg | ¥ 9,870 | In Stock | |
| 50 mg | ¥ 13,800 | In Stock | |
| 100 mg | ¥ 18,900 | In Stock |
Opigolix 相关产品
| 产品描述 | Opigolix (ASP-1707) is an orally available gonadotropin-releasing hormone (GnRH) receptor antagonist for the study of endometriosis-related pain, rheumatoid arthritis, and uterine fibroids. |
| 别名 | ASP-1707 |
| 分子量 | 544.5 |
| 分子式 | C25H19F3N4O5S |
| CAS No. | 912587-25-8 |
| Smiles | C(C(=O)C1=CC(S(NC([C@@H](C)O)=N)(=O)=O)=C(F)C=C1)(C(=O)C2=C(F)C=CC(F)=C2)=C3NC=4C(N3)=CC=CC4 |
| 密度 | 1.55 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容